28432944|t|Phototoxic action of a zinc(II) phthalocyanine encapsulated into poloxamine polymeric micelles in 2D and 3D colon carcinoma cell cultures
28432944|a|Photodynamic therapy is emerging as a hopeful method for the treatment of oncological diseases. In the search of novel therapeutic strategies for colorectal cancer, in this work we reported the photocytotoxic activity of a lipophilic zinc(II) phthalocyanine on a murine colon adenocarcinoma cell line (CT26 cells). The 2,9(10),16(17),23(24) tetrakis[(2-dimethylamino)ethylsulfanyl]phthalocyaninatozinc(II), named Pc9, was encapsulated into Tetronic® 1107 polymeric poloxamine micelles (T1107) and assayed in 2D and 3D cell cultures. We showed that the formulation Pc9 - T1107 was efficient to reduce cell viability after photodynamic treatment both in 2D cultures (IC50 10±2nM) as well as in CT26 spheroids (IC50 370±11nM). Cellular uptake of Pc9 - T1107 was a time- and concentration-dependent process, being the phthalocyanine formulation mainly incorporated into lysosomal vesicles and endoplasmic reticulum cisterns, but not in mitochondria. Pc9 - T1107 also induced the formation of reactive oxygen species immediately after cell irradiation. We also found that the phototoxic action of Pc9 - T1107 was partially reversed in the presence of antioxidants, such as TROLOX and N-acetyl-cysteine. In addition, we showed that Pc9 - T1107 treatment triggered an apoptotic cell death, as suggested by the detection of pyknotic nuclei, the reduction in the expression levels of procaspase-3 and the increase in caspase-3 enzymatic activity.
28432944	0	17	Phototoxic action	T169	C1511636
28432944	23	46	zinc(II) phthalocyanine	T109,T121	C0078832
28432944	47	59	encapsulated	T080	C0205223
28432944	65	75	poloxamine	T109,T121	C1876683
28432944	76	94	polymeric micelles	T109	C0025938
28432944	98	100	2D	T082	C1705052
28432944	105	107	3D	T082	C0450363
28432944	108	123	colon carcinoma	T191	C0699790
28432944	124	137	cell cultures	T059	C0007585
28432944	138	158	Photodynamic therapy	T061	C0031740
28432944	184	190	method	T169	C0449851
28432944	199	208	treatment	T061	C0087111
28432944	212	232	oncological diseases	T047	C0012634
28432944	257	279	therapeutic strategies	T170	C0679716
28432944	284	301	colorectal cancer	T191	C1527249
28432944	332	355	photocytotoxic activity	T169	C1511636
28432944	361	371	lipophilic	T081	C0598631
28432944	372	395	zinc(II) phthalocyanine	T109,T121	C0078832
28432944	401	407	murine	T015	C0026809
28432944	408	428	colon adenocarcinoma	T191	C0338106
28432944	429	438	cell line	T025	C0007600
28432944	440	450	CT26 cells	T025	C0007634
28432944	457	543	2,9(10),16(17),23(24) tetrakis[(2-dimethylamino)ethylsulfanyl]phthalocyaninatozinc(II)	T121	C1254351
28432944	551	554	Pc9	T121	C1254351
28432944	560	572	encapsulated	T080	C0205223
28432944	578	592	Tetronic® 1107	T109,T121	C0675004
28432944	593	622	polymeric poloxamine micelles	T109,T121	C1876683
28432944	624	629	T1107	T109,T121	C0675004
28432944	646	648	2D	T082	C1705052
28432944	653	655	3D	T082	C0450363
28432944	656	669	cell cultures	T059	C0007585
28432944	690	701	formulation	T077	C1705957
28432944	702	705	Pc9	T121	C1254351
28432944	708	713	T1107	T109,T121	C0675004
28432944	731	737	reduce	T080	C0392756
28432944	738	752	cell viability	T043	C0007620
28432944	759	781	photodynamic treatment	T061	C0031740
28432944	790	792	2D	T082	C1705052
28432944	793	801	cultures	T059	C0007585
28432944	803	807	IC50	T081	C0600495
28432944	830	844	CT26 spheroids	T025	C0282501
28432944	846	850	IC50	T081	C0600495
28432944	862	877	Cellular uptake	T043	C0007613
28432944	881	884	Pc9	T121	C1254351
28432944	887	892	T1107	T109,T121	C0675004
28432944	899	904	time-	T067	C1522240
28432944	909	940	concentration-dependent process	T067	C1522240
28432944	952	966	phthalocyanine	T109,T121	C0078832
28432944	967	978	formulation	T077	C1705957
28432944	1004	1013	lysosomal	T029	C0521450
28432944	1014	1022	vesicles	T026	C1622418
28432944	1027	1057	endoplasmic reticulum cisterns	T026	C1166837
28432944	1070	1082	mitochondria	T026	C0026237
28432944	1084	1087	Pc9	T121	C1254351
28432944	1090	1095	T1107	T109,T121	C0675004
28432944	1101	1108	induced	T169	C0205263
28432944	1113	1122	formation	T169	C1522492
28432944	1126	1149	reactive oxygen species	T123,T196	C0162772
28432944	1168	1172	cell	T025	C0007634
28432944	1173	1184	irradiation	T070	C1282930
28432944	1209	1226	phototoxic action	T169	C1511636
28432944	1230	1233	Pc9	T121	C1254351
28432944	1236	1241	T1107	T109,T121	C0675004
28432944	1246	1255	partially	T081	C0728938
28432944	1256	1264	reversed	T169	C0205245
28432944	1284	1296	antioxidants	T121	C0003402
28432944	1306	1312	TROLOX	T109,T121	C0147003
28432944	1317	1334	N-acetyl-cysteine	T116,T121	C0001047
28432944	1364	1367	Pc9	T121	C1254351
28432944	1370	1375	T1107	T109,T121	C0675004
28432944	1376	1385	treatment	T061	C0087111
28432944	1386	1395	triggered	T080	C1444748
28432944	1399	1420	apoptotic cell death,	T043	C0162638
28432944	1441	1450	detection	T033	C0442726
28432944	1454	1462	pyknotic	T043	C0333904
28432944	1463	1469	nuclei	T026	C0007610
28432944	1475	1484	reduction	T080	C0392756
28432944	1492	1502	expression	T045	C1171362
28432944	1503	1509	levels	T080	C0441889
28432944	1513	1525	procaspase-3	T116,T126	C0758915
28432944	1534	1542	increase	T169	C0442805
28432944	1546	1555	caspase-3	T116,T126	C0291573
28432944	1556	1574	enzymatic activity	T044	C2267219